Can you provide the average price target for ZOMEDICA CORP stock?
5 analysts have analysed ZOM and the average price target is 0.26 USD. This implies a price increase of 162.08% is expected in the next year compared to the current price of 0.0973.
NYSEARCA:ZOM • CA98980M1095
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZOMEDICA CORP (ZOM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-01-06 | Dawson James | Initiate | Buy |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.133M | 18.93M 358.01% | 25.186M 33.05% | 27.775M 10.28% | 35.552M 28.00% | 45.783M 28.78% | 59.166M 29.23% | |
| EBITDA YoY % growth | -20.228M -24.60% | -17.881M 11.60% | -25.294M -41.46% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -21.368M -27.46% | -21.923M -2.60% | -31.592M -44.10% | -51.413M -62.74% | -35.525M 30.90% | -33.999M 4.30% | -36.988M -8.79% | |
| Operating Margin | -517.00% | -115.81% | -125.43% | -185.11% | -99.92% | -74.26% | -62.52% | |
| EPS YoY % growth | N/A | N/A | -0.02 -13.86% | -0.05 -110.78% | -0.03 37.50% | -0.03 10.00% | -0.03 -11.11% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 29.30% | -0.01 19.20% | -0.01 | -0.01 19.20% | -0.01 -14.29% |
| Revenue Q2Q % growth | 8.181M 11.50% | 7.878M 25.85% | 8.585M 40.05% | 8.989M 28.41% | 10.1M 23.46% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.091M 28.96% | -8.879M 14.51% | -8.784M 2.86% | -8.993M -20.87% | -8.869M -9.61% |
All data in USD
5 analysts have analysed ZOM and the average price target is 0.26 USD. This implies a price increase of 162.08% is expected in the next year compared to the current price of 0.0973.
ZOMEDICA CORP (ZOM) will report earnings on 2025-05-07.
The consensus EPS estimate for the next earnings of ZOMEDICA CORP (ZOM) is -0.01 USD and the consensus revenue estimate is 8.18M USD.
The consensus rating for ZOMEDICA CORP (ZOM) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.